Navigation Links
SUVmax provides valuable indicator of progression-free survival in stage I NSCLC patients
Date:2/8/2013

Orlando, Fla., February 8, 2013 SUVmax (Maximum Standardized Uptake Value) may be a significant and clinically independent marker to indicate progression-free survival in stage I non-small cell lung cancer (NSCLC) patients treated with stereotactic body radiation therapy (SBRT), according to research being presented at the 2013 Cancer Imaging and Radiation Therapy Symposium. This Symposium is sponsored by the American Society for Radiation Oncology (ASTRO) and the Radiological Society of North American (RSNA).

SUVmax is measured via PET/CT scan after patients have been injected with radioactive sugar (glucose). Quantifying the SUV of suspicious lesions can aid the identification of early stage tumors because cells that take in greater than normal amounts of radioactive glucose have a higher likelihood of being tumor cells. The highest concentration of radioactive glucose represents SUVmax. Previous studies have been able to correlate SUVmax to the growth rate of tumors, which indicates that tumors with higher SUVmax will more likely be more rapidly growing and will therefore be tumors that are more difficult to treat, may recur or may metastasize more frequently.

This study included 95 medically inoperable NSCLC patients from October 2005 through May 2011, with a median age of 77 years. All patients had peripheral tumors, and no patient had been previously treated for lung cancer. Prior to SBRT treatment, all patients had an PET/CT scan with documented pretreatment SUVmax assessment. SBRT fractionation was 60 Gy in three (3) fractions with a median treatment time of six days (range of three to 21 days). With a median follow-up of 15 months, median overall survival was 25.3 months and progression-free survival was 40.3 months. Tumor control, overall and progression-free survival were derived utilizing the Kaplan-Meier method, and Cox proportional hazards regression was performed to determine whether SUVmax, age, Karnofsky Performance Status, gender, tumor size/T-stage or smoking history influenced outcomes.

"If SUVmax is assessed prior to radiation therapy, specific strategies could be developed to tailor treatments for patients, which would, in turn, provide them with the best chance at a longer and disease-free survival," said Zachary Horne, a 2013 MD candidate at the George Washington University School of Medicine in Washington, D.C., the lead study author and a researcher in the radiation oncology department at the University of Pittsburgh Cancer Institute. "Accurate anatomical and functional imaging and assessment, such as SUVmax, can help us achieve improved outcomes for patients."


'/>"/>

Contact: Michelle Kirkwood
press@astro.org
703-286-1600
American Society for Radiation Oncology
Source:Eurekalert

Related medicine news :

1. DAI provides potential imaging biomarker to indicate brain tumor response to RT
2. Premium Astrology Launches New Site -- Astro Answer -- Provides Support for Customer Service Satisfaction
3. Transvaginal Mesh Lawsuit Website Launched by Bernstein Liebhard LLP Provides Updated Information on Vaginal Mesh Side Effects, Growing Litigation
4. Expert Revivogen Provides Tips and Education to Prevent Hair Loss, Recommends Starting a Preventative Hair Loss Regimen to Stop the Condition Before it Advances
5. Hearing Aid Device Expert of Upstate Hearing Instruments Provides 7 Key Tips to Encourage Hearing Aid Adoption within the Elderly Populations
6. Medical cannabis provides dramatic relief for sufferers of chronic ailments
7. Xocai's New Xe Product Provides An Incentive For Marketing Xocolate International Corporation (MXI Corp) Distributors To Launch Their Business To A Whole New Level
8. LSUHSC research provides new drug target for Her-2 related breast cancer
9. Guided care provides better quality of care for chronically ill older adults
10. Director of the Center for Craniofacial & Dental Sleep Medicine Provides New Cutting Edge Technology for Patients Suffering with Obstructive Sleep Apnea
11. Pill-sized device provides rapid, detailed imaging of esophageal lining
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/27/2017)... (PRWEB) , ... June 27, 2017 , ... ... management assistance and personal financial planning services to residents of southern New Hampshire, ... charity event that promises to fight hunger and homelessness in the region. , ...
(Date:6/27/2017)... ... ... Hammer Strength, the world’s leading performance strength training brand, and the National Basketball ... NBSCA Strength & Conditioning Coach of the Year. , In its 11th year, ... the coach who embodies the highest level of excellence and outstanding service to their ...
(Date:6/26/2017)... ... ... Torrance dentist, Dr. Robert Mondavi DDS , is now offering comprehensive cosmetic ... person’s appearance. A healthy, radiant smile can make a person look more attractive, youthful, ... the smile of their dreams with cosmetic dentistry. , “The field of dentistry is ...
(Date:6/26/2017)... Ruidoso, New Mexico (PRWEB) , ... June 26, ... ... sexual dysfunction, anorgasmia, and urinary leakage is revolutionizing the way women look and ... Mexico is tackling the problem of female sexual dysfunction and urinary leakage head ...
(Date:6/25/2017)... ... 25, 2017 , ... FCPX LUT Vintage Volume 2 for Final Cut Pro ... Vintage Volume 2 contains 60 different color-grade presets, giving editors multiple options for adding ... to single out subjects, plus much more. FCPX LUT Vintage Volume 2 is designed ...
Breaking Medicine News(10 mins):
(Date:6/5/2017)... , June 5, 2017 Kohll,s Pharmacy & Homecare is ... the United States . The Raizer is a ... fallen person up to an almost-standing position within ... operated by one assistant and does not require ... enough that a child can operate it, and ...
(Date:6/1/2017)... , June 1, 2017 Nutriceutical Holdings (NH), ... Recommended Solutions (VRS), and KD Pharma Group have decided ... Holdings by KD Pharma Group. KD Pharma Group will ... option to acquire the entire company. "We ... They are committed to growing the NH companies by ...
(Date:5/30/2017)... AVIV, Israel , May 30, 2017 ... stage pharmaceutical Company specializing in the development of ... will present a company overview at three upcoming ... The 7th Annual LD Micro Invitational: ... Date:                     ...
Breaking Medicine Technology: